Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page
- CheckyesterdayChange DetectedUpgraded Revision from v3.0.1 to v3.0.2, and removed the Back to Top element. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as detailed information on various hematologic diseases and treatments, including a new clinical trial reference. Some previously listed terms and conditions have been removed.SummaryDifference8%
- Check23 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.7%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.6%
Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.